|
Clinical Pharmacology Unit (CPU)
Our company provides comprehensive services tailored to meet the needs of new drug investigations in human. This CPU provides the opportunity for early human administration of each compound.
Phase I & IIA Clinical Pharmacology Services:
- First-into-man studies
- Rising Dose Tolerance
- Pharmacokinetic
- Dose Response
- Bioequivalence studies
- Bioavailabitily
- Drug Interaction studies
- Data Management
- AE Review/Reporting
- QA
- Statistics
- Protocol & Study Design
- CRF Design
Our experienced professionals are able to provide comprehensive consultation services throughout the development process. The facilities, clinical expertise and optimal regulatory environment can significantly reduce Phase I and IIA development time, while delivering the highest quality of data.
For more information on the Research & Development RA SA CPU, please contact: Dr. Adriana Sanchez at adrianasanchez@rd-latam.com
|
